{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:23:56Z","timestamp":1791433436576,"version":"4.3.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12022-021-09684-z","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:02:26Z","timestamp":1622073746000},"page":"433-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Middle Ear \u201cAdenoma\u201d: a Neuroendocrine Tumor with Predominant L Cell Differentiation"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knarik","family":"Arkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Tischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayardo","family":"Perez-Ordonez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Wenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"issue":"1","key":"9684_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2273.1976.tb00637.x","volume":"1","author":"VJ Hyams","year":"1976","unstructured":"Hyams VJ, Michaels L. Benign adenomatous neoplasm (adenoma) of the middle ear. Clin Otolaryngol Allied Sci 1976;1(1):17-26.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"2","key":"9684_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/ajcp\/77.2.153","volume":"77","author":"WG Riches","year":"1982","unstructured":"Riches WG, Johnston WH. Primary adenomatous neoplasms of the middle ear: light and electron microscopic features of a group distinct from the ceruminomas. Am J Clin Pathol 1982 Feb;77(2):153-61.","journal-title":"Am J Clin Pathol"},{"issue":"11 Pt 1","key":"9684_CR3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1288\/00005537-198411000-00018","volume":"94","author":"X Kochilas","year":"1984","unstructured":"Kochilas X, Birchall JP, Sloan P. Light and electron microscopic studies of a case of middle ear adenoma. Laryngoscope 1984 Nov;94(11 Pt 1):1482-4.","journal-title":"Laryngoscope"},{"key":"9684_CR4","doi-asserted-by":"crossref","unstructured":"McNutt MA, Bolen JW. Adenomatous tumor of the middle ear. An ultrastructural and immunocytochemical study. Am J Clin Pathol 1985 Oct;84(4):541\u20137.","DOI":"10.1093\/ajcp\/84.4.541"},{"issue":"4","key":"9684_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1017\/S0022215100099497","volume":"100","author":"QR Bailey","year":"1986","unstructured":"Bailey QR, Weiner JM. Middle ear adenoma: a case report with ultrastructural findings. J Laryngol Otol 1986 Apr;100(4):467-70.","journal-title":"J Laryngol Otol"},{"issue":"1","key":"9684_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/019131201300004717","volume":"25","author":"S Ketabchi","year":"2001","unstructured":"Ketabchi S, Massi D, Franchi A, Vannucchi P, Santucci M. Middle ear adenoma is an amphicrine tumor: why call it adenoma? Ultrastruct Pathol 2001 Jan;25(1):73-8.","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"9684_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/modpathol.3880561","volume":"15","author":"KR Torske","year":"2002","unstructured":"Torske KR, Thompson LD. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 2002 May;15(5):543-55.","journal-title":"Mod Pathol"},{"issue":"3","key":"9684_CR8","first-page":"199","volume":"130","author":"N Angouridakis","year":"2009","unstructured":"Angouridakis N, Hytiroglou P, Markou K, Bouzakis A, Vital V. Middle ear adenoma\/carcinoid tumour: a case report and review of the literature. Rev Laryngol Otol Rhinol (Bord ) 2009;130(3):199-202.","journal-title":"Rev Laryngol Otol Rhinol (Bord )"},{"issue":"2","key":"9684_CR9","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1186\/1757-1626-0002-0000006508","volume":"13","author":"I Saliba","year":"2009","unstructured":"Saliba I, Evrard AS. Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases J 2009 Mar 13;2:6508.","journal-title":"Cases J"},{"issue":"3","key":"9684_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4103\/ijri.IJRI_125_20","volume":"30","author":"M Pontico","year":"2020","unstructured":"Pontico M, Frantellizzi V, Cosma L, De VG. 111In-Octreoscan SPECT\/CT hybrid imaging and 68Ga-DOTANOC PET\/CT in neuroendocrine adenoma of the middle ear (NAME). Indian J Radiol Imaging 2020 Jul;30(3):400-4.","journal-title":"Indian J Radiol Imaging"},{"key":"9684_CR11","doi-asserted-by":"crossref","unstructured":"van der Lans RJL, Engel MSD, Rijken JA, Hensen EF, Bloemena E, van der Torn M, Leemans CR, Smit CFGM. Neuroendocrine neoplasms of the middle ear: Unpredictable tumor behavior and tendency for recurrence. Head Neck 2021 Feb 19.","DOI":"10.1002\/hed.26658"},{"issue":"7","key":"9684_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/hed.20197","volume":"27","author":"R Pellini","year":"2005","unstructured":"Pellini R, Ruggieri M, Pichi B, Covello R, Danesi G, Spriano G. A case of cervical metastases from temporal bone carcinoid. Head Neck 2005 Jul;27(7):644-7.","journal-title":"Head Neck"},{"issue":"9","key":"9684_CR13","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1097\/01.mlg.0000175069.13685.37","volume":"115","author":"MJ Ramsey","year":"2005","unstructured":"Ramsey MJ, Nadol JB, Jr., Pilch BZ, McKenna MJ. Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases. Laryngoscope 2005 Sep;115(9):1660-6.","journal-title":"Laryngoscope"},{"issue":"5","key":"9684_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00428-017-2155-6","volume":"471","author":"D Bell","year":"2017","unstructured":"Bell D, El-Naggar AK, Gidley PW. Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center. Virchows Arch 2017 Nov;471(5):667-72.","journal-title":"Virchows Arch"},{"issue":"8","key":"9684_CR15","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1097\/MAO.0000000000001905","volume":"39","author":"JP Marinelli","year":"2018","unstructured":"Marinelli JP, Cass SP, Mann SE, Haynes DS, Hunter JB, Isaacson B, Sweeney AD, Pelosi S, Willcox TO, O'Connell BP, Rivera M, Lane JI, Carlson ML. Adenomatous Neuroendocrine Tumors of the Middle Ear: A Multi-institutional Investigation of 32 Cases and Development of a Staging System. Otol Neurotol 2018 Sep;39(8):e712-e721.","journal-title":"Otol Neurotol"},{"issue":"12","key":"9684_CR16","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Kloppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 2018 Dec;31(12):1770-86.","journal-title":"Mod Pathol"},{"key":"9684_CR17","volume-title":"Pituitary Neuroendocrine Tumors: A Model for Neuroendocrine Tumor Classification","author":"SL Asa","year":"2021","unstructured":"Asa S.L., Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S., Grossman AB, Ezzat S. Pituitary Neuroendocrine Tumors: A Model for Neuroendocrine Tumor Classification. Mod Pathol. In press 2021."},{"issue":"2","key":"9684_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.12447","volume":"66","author":"A Agaimy","year":"2015","unstructured":"Agaimy A, Lell M, Schaller T, Markl B, Hornung J. 'Neuroendocrine' middle ear adenomas: consistent expression of the transcription factor ISL1 further supports their neuroendocrine derivation. Histopathology 2015 Jan;66(2):182-91.","journal-title":"Histopathology"},{"key":"9684_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00236925","volume":"213","author":"JC Garaud","year":"1980","unstructured":"Garaud JC, Eloy R, Moody AJ, Stock C, Grenier JF. Glucagon- and glicentin-immunoreactive cells in the human digestive tract. Cell Tissue Res 1980;213:121-36.","journal-title":"Cell Tissue Res"},{"key":"9684_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/BF00215697","volume":"221","author":"PC Colony","year":"1982","unstructured":"Colony PC, Helmstaedter V, Moody AJ, Garaud JC, Forssmann WG. Glucagon and glicentin immunoreactive cells in human colon. Cell Tissue Res 1982;221:483-91.","journal-title":"Cell Tissue Res"},{"key":"9684_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0167-0115(84)90034-X","volume":"8","author":"G B\u00f6ttcher","year":"1984","unstructured":"B\u00f6ttcher G, Sj\u00f6lund K, Ekblad E, H\u00e5kanson R, Schwartz TW, Sundler F. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept 1984;8:261-6.","journal-title":"Regul Pept"},{"key":"9684_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0167-0115(86)90046-7","volume":"13","author":"G B\u00f6ttcher","year":"1986","unstructured":"B\u00f6ttcher G, Alumets J, H\u00e5kanson R, Sundler F. Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study. Regul Pept 1986;13:283-91.","journal-title":"An electron microscopic study. Regul Pept"},{"issue":"4","key":"9684_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4143\/crt.2014.238","volume":"47","author":"JH Sohn","year":"2015","unstructured":"Sohn JH, Cho MY, Park Y, Kim H, Kim WH, Kim JM, Jung ES, Kim KM, Lee JH, Chan HK, Park DY, Joo M, Kim S, Moon WS, Kang MS, Jin SY, Kang YK, Yoon SO, Han H, Choi E. Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters. Cancer Res Treat 2015 Oct;47(4):813-22.","journal-title":"Cancer Res Treat"},{"issue":"5","key":"9684_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/PAS.0000000000000400","volume":"39","author":"JY Kim","year":"2015","unstructured":"Kim JY, Kim KS, Kim KJ, Park IJ, Lee JL, Myung SJ, Park Y, Park YS, Yu CS, Kim JC, Yu E, Jang HJ, Hong SM. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis. Am J Surg Pathol 2015 May;39(5):632-43.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"9684_CR25","first-page":"7072","volume":"8","author":"Z Li","year":"2015","unstructured":"Li Z, Yuan J, Wei L, Zhou L, Mei K, Yue J, Gao H, Zhang M, Jia L, Kang Q, Huang X, Cao D. SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors. Int J Clin Exp Pathol 2015;8(6):7072-82.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"9684_CR26","doi-asserted-by":"publisher","first-page":"152448","DOI":"10.1016\/j.prp.2019.152448","volume":"215","author":"LH Zhao","year":"2019","unstructured":"Zhao LH, Chen C, Mao CY, Xiao H, Fu P, Xiao HL, Wang G. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors. Pathol Res Pract 2019 Jul;215(7):152448.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"9684_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/his.13943","volume":"76","author":"AM Bellizzi","year":"2020","unstructured":"Bellizzi AM. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Histopathology 2020 Jan;76(2):251-64.","journal-title":"Histopathology"},{"issue":"4","key":"9684_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/his.14012","volume":"76","author":"D Hoskoppal","year":"2020","unstructured":"Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Histopathology 2020 Mar;76(4):550-9.","journal-title":"Histopathology"},{"key":"9684_CR29","unstructured":"Tischler AS, Asa SL. Paraganglia. In: Mills SE, editor. Histology for Pathologists.Philadelphia: Wolters Kluwer; 2018."},{"key":"9684_CR30","doi-asserted-by":"crossref","unstructured":"Asa SL, Ezzat S, Mete O. The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations. J Clin Med 2018 Sep 13;7(9).","DOI":"10.3390\/jcm7090280"},{"issue":"1","key":"9684_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/his.13402","volume":"72","author":"J Turchini","year":"2018","unstructured":"Turchini J, Cheung VKY, Tischler AS, de Krijger RR, Gill AJ. Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology 2018 Jan;72(1):97-105.","journal-title":"Histopathology"},{"key":"9684_CR32","doi-asserted-by":"crossref","unstructured":"Mete O, Pakbaz S, Lerario AM, Giordano TJ, Asa SL. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas. Am J Surg Pathol 2021 Apr 8.","DOI":"10.1097\/PAS.0000000000001715"},{"key":"9684_CR33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fgene.2020.00358","volume":"11","author":"AF Ryan","year":"2020","unstructured":"Ryan AF, Nasamran CA, Pak K, Draf C, Fisch KM, Webster N, Kurabi A. Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection. Front Genet 2020;11:358.","journal-title":"Front Genet"},{"key":"9684_CR34","doi-asserted-by":"crossref","unstructured":"van Waegeningh HF, Ebbens FA, van SE, Oostra RJ. Single origin of the epithelium of the human middle ear. Mech Dev 2019 Aug;158:103556.","DOI":"10.1016\/j.mod.2019.103556"},{"key":"9684_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/00016488409122876","volume":"414","author":"E Hentzer","year":"1984","unstructured":"Hentzer E. Ultrastructure of the middle ear mucosa. Acta Otolaryngol Suppl 1984;414:19-27.","journal-title":"Acta Otolaryngol Suppl"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-021-09684-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09684-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T05:57:46Z","timestamp":1699077466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-021-09684-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9684"],"URL":"https:\/\/doi.org\/10.1007\/s12022-021-09684-z","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"18 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional ethics review board at participating hospitals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All the authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Ozgur Mete is the Editor-in-Chief of Endocrine Pathology. This article was handled by an independent senior editor and peer-reviewed as per the journal standards. The\u00a0remaining authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}